Over 1 million Americans suffer a myocardial infarction (MI) each year and many experience post-MI left ventricular (LV) remodeling, which is manifest as progressive changes in LV structure and function. Post-MI LV remodeling is responsible for nearly 70% of all heart failure (HF) cases. HF severely disables 5 million Americans and kills more than 250,000 each year. The proposed project is based on a highly significant translational research approach that seeks to develop a clinically applicable, minimally invasive treatment strategy focused on the newly formed MI intended to interrupt LV remodeling and prevent the development of symptomatic HF. Infarct expansion (stretching) results from progressive changes in MI material properties and has been identified as the biomechanical phenomena that initiates and sustains adverse LV remodeling. The proposed project will build on and advance our previously completed work, which demonstrated that preventing infarct expansion by surgically placed restraint devices significantly reduces LV remodeling. The overarching goal of this project is to establish that targeted delivery of novel biomaterials that have been engineered to induce a phenotypic shift in responding macrophages from the M1 (proteolytic) phenotype to the M2 (reparative) phenotype, will promote extracellular matrix (ECM) stability, favorably alter infarct material properties, limit infarct expansion and improve LV remodeling.
In Specific Aim 1 we will test the hypothesis that targeted delivery of monocyte chemoattractant protein-1 (MCP-1) into the infarct region by a hyaluronic acid (HA) hydrogel carrier shifts responding macrophage polarization in favor of the M2 phenotype, which promotes ECM stability, favorably alters infarct material properties, limits infarct expansion and improves LV remodeling.
In Specific Aim 2 we will test the hypothesis that the targeted delivery to the infarct region of PLGA microspheres and MCP-1 in a HA-hydrogel carrier will synergistically potentiate both macrophage polarization in favor of the M2 phenotype and ECM stability further reducing infarct expansion and limiting LV remodeling when compared to PLGA microspheres or MCP-1 delivery alone. The significance of the proposed project is further enhanced by the use of a clinically relevant large animal MI model and the application in Specific Aim 3 of minimally invasive catheter-based epicardial approaches for biomaterial delivery guided by state-of-the-art electroanatomic infarct mapping. Both of which heighten the potential for rapid clinical translation of the proposed work.
Left ventricular remodeling (enlargement of the heart) after myocardial infarction (heart attack) is the most common cause of heart failure in the United States and kills over 250,000 Americans every year. The intent of this proposal is to engineer and test an optimized hyaluronic acid-based hydrogel material that can be delivered into the infarct region to mechanically stabilize the heart early after a myocardial infarction to prevent heart failure. The successful completion of the project would likely lead to a non-invasive means for reducing the incidence of heart failure.
|Wang, Hua; Rodell, Christopher B; Zhang, Xiaoyan et al. (2018) Effects of hydrogel injection on borderzone contractility post-myocardial infarction. Biomech Model Mechanobiol 17:1533-1542|
|Avazmohammadi, Reza; Li, David S; Leahy, Thomas et al. (2018) An integrated inverse model-experimental approach to determine soft tissue three-dimensional constitutive parameters: application to post-infarcted myocardium. Biomech Model Mechanobiol 17:31-53|
|Chen, Carol W; Wang, Leo L; Zaman, Samir et al. (2018) Sustained release of endothelial progenitor cell-derived extracellular vesicles from shear-thinning hydrogels improves angiogenesis and promotes function after myocardial infarction. Cardiovasc Res 114:1029-1040|
|Wang, Leo L; Chung, Jennifer J; Li, Elizabeth C et al. (2018) Injectable and protease-degradable hydrogel for siRNA sequestration and triggered delivery to the heart. J Control Release 285:152-161|
|Zgheib, Carlos; Hodges, Maggie M; Allukian, Myron W et al. (2017) Cardiac Progenitor Cell Recruitment Drives Fetal Cardiac Regeneration by Enhanced Angiogenesis. Ann Thorac Surg 104:1968-1975|
|Bavo, A M; Pouch, A M; Degroote, J et al. (2017) Patient-specific CFD models for intraventricular flow analysis from 3D ultrasound imaging: Comparison of three clinical cases. J Biomech 50:144-150|
|Mahmood, Feroze; Knio, Ziyad O; Yeh, Lu et al. (2017) Regional Heterogeneity in the Mitral Valve Apparatus in Patients With Ischemic Mitral Regurgitation. Ann Thorac Surg 103:1171-1177|
|Wang, Hua; Rodell, Christopher B; Lee, Madonna E et al. (2017) Computational sensitivity investigation of hydrogel injection characteristics for myocardial support. J Biomech 64:231-235|
|Stoffers, Rutger H; Madden, Marie; Shahid, Mohammed et al. (2017) Assessment of myocardial injury after reperfused infarction by T1? cardiovascular magnetic resonance. J Cardiovasc Magn Reson 19:17|
|Contijoch, Francisco; Iyer, Srikant Kamesh; Pilla, James J et al. (2017) Self-gated MRI of multiple beat morphologies in the presence of arrhythmias. Magn Reson Med 78:678-688|
Showing the most recent 10 out of 161 publications